Korppi M, Leinonen M, Ruuskanen O
Pediatric Research Center, Tampere University and University Hospital, FinMed-3, 33014 Tampere, Finland.
Eur J Clin Microbiol Infect Dis. 2008 Mar;27(3):167-75. doi: 10.1007/s10096-007-0436-8. Epub 2007 Dec 18.
The role of Streptococcus pneumoniae in the etiology of respiratory tract infections has been studied serologically using microbe-specific antibody and immune complex assays. Serological methods are sensitive in the bacteremic pneumococcal pneumonia of adults. In children, however, pneumococcal pneumonia is seldom bacteremic, and, thus, in the absence of a gold standard for the detection of pneumococcal infection, serological methods are still insufficiently validated. We report here indirect evidence for the sensitivity and specificity of pneumococcal serology in children. Serological evidence of pneumococcal infection has been found in 27% to 38% of children with radiologically confirmed pneumonia, in 7% to 8% of children with viral wheezy bronchitis, and in <1% to 5% of children and young adults with viral upper respiratory infection. Serological findings for pneumococcal infection have been dependent on the study venue, whether in hospital or ambulatory subjects, and on the test panel used. Where both antibody and immune complex assays have been available, the proportion of children with pneumococcal infection has been 32% to 37% in inpatients and 27% to 28% in outpatients. The respective rates have been 10% to 18% by antibody assays alone. Pneumococcal acute otitis media, when present with pneumonia, may confound findings in pneumococcal serology, but pure nasopharyngeal carriage of S. pneumoniae has little effect. In contrast, carriage acquisition of a new serotype may induce significant antibody production. Thus, understandably, significant rises between paired sera in antibodies to pneumococcal capsular polysaccharides and pneumococcal pneumolysin have been found in <1% to 3% of non-symptomatic children and young adults. Findings from the last 20 years indirectly suggest that pneumococcal antibody and immune complex assays are sensitive and specific enough for the detection of pneumococcal infection in children. However, the methods are too complex for routine clinical practice, and, so far, serological methods for S. pneumoniae infections have only been used for research purposes.
肺炎链球菌在呼吸道感染病因学中的作用已通过使用微生物特异性抗体和免疫复合物检测进行血清学研究。血清学方法对成人菌血症性肺炎链球菌肺炎敏感。然而,在儿童中,肺炎链球菌肺炎很少有菌血症,因此,在缺乏检测肺炎链球菌感染金标准的情况下,血清学方法仍未得到充分验证。我们在此报告儿童肺炎链球菌血清学敏感性和特异性的间接证据。在影像学确诊为肺炎的儿童中,27%至38%发现有肺炎链球菌感染的血清学证据;在病毒性喘息性支气管炎儿童中,7%至8%有该证据;在病毒性上呼吸道感染的儿童和青年中,该证据的比例<1%至5%。肺炎链球菌感染的血清学结果取决于研究场所,无论是在医院还是门诊受试者,也取决于所使用的检测组。在同时有抗体和免疫复合物检测的情况下,住院儿童中肺炎链球菌感染的比例为32%至37%,门诊儿童为27%至28%。仅通过抗体检测,相应比例为10%至18%。肺炎链球菌急性中耳炎与肺炎同时存在时,可能会混淆肺炎链球菌血清学的结果,但单纯肺炎链球菌鼻咽部携带影响不大。相比之下,获得新血清型的携带可能会诱导显著的抗体产生。因此,可以理解的是,在<1%至3%的无症状儿童和青年中,发现肺炎链球菌荚膜多糖抗体和肺炎链球菌溶血素抗体在配对血清之间有显著升高。过去20年的研究结果间接表明,肺炎链球菌抗体和免疫复合物检测对于检测儿童肺炎链球菌感染足够敏感和特异。然而,这些方法对于常规临床实践来说过于复杂,到目前为止,肺炎链球菌感染的血清学方法仅用于研究目的。